93 related articles for article (PubMed ID: 2009508)
21. Chronic myelomonocytic leukemia with t(1;3)(p36;q21) and a synchronous gastric cancer.
Fujisawa S; Harano H; Yamazaki E; Motomura S; Mohri H; Ishigatsubo Y
Am J Med Sci; 2000 Apr; 319(4):258-60. PubMed ID: 10768613
[TBL] [Abstract][Full Text] [Related]
22. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association.
Berkowicz M; Rosner E; Rechavi G; Mamon Z; Neuman Y; Ben-Bassat I; Ramot B
Cancer Genet Cytogenet; 1991 Feb; 51(2):277-8. PubMed ID: 1993313
[No Abstract] [Full Text] [Related]
23. Therapy-related chronic myelomonocytic leukemia with unique chromosomal abnormalities: monosomy 7 and t(12;17)(p13;q11.2).
Oo TH; Kenney L
Am J Hematol; 2007 Mar; 82(3):248-9. PubMed ID: 16924641
[No Abstract] [Full Text] [Related]
24. [Double t (3; 21) in acute myelomonocytic leukemia transformed from chronic myelomonocytic leukemia].
Arai Y; Handa T; Nakamura F; Takahashi W; Maki K; Mitani K
Rinsho Ketsueki; 2002 Sep; 43(9):865-7. PubMed ID: 12412294
[TBL] [Abstract][Full Text] [Related]
25. [Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)].
Ozawa M; Iwamoto K; Kitani K; Mizuno T; Kobayashi Y; Horiuchi H; Maruo N; Kondo M; Horiike S; Misawa S
Rinsho Ketsueki; 1988 Dec; 29(12):2297-301. PubMed ID: 3246714
[No Abstract] [Full Text] [Related]
26. Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia.
Saumell S; Florensa L; Rodríguez-Rivera M; Pedro C; Hernández-Rivas JM; Lumbreras E; Abáigar M; Collado R; Ivars D; Carbonell F; Marugán I; Tormo M; Botia M; Piñan MÁ; Ancín I; González T; Varela ND; Grau J; Granada I; Ruiz N; Martín ML; Fernández-Guijarro M; Duarte JJ; Calasanz MJ; Larrayoz MJ; Solé F
Leuk Lymphoma; 2015 Jan; 56(1):242-3. PubMed ID: 24724779
[No Abstract] [Full Text] [Related]
27. [A cytogenetic and clinico-genealogical analysis of chronic myelomonocytic leukemia in a child].
Kitsera NI; Polishchuk RS; Koziĭ RO; Sirenko AH
Lik Sprava; 1999; (1):129-31. PubMed ID: 10424025
[No Abstract] [Full Text] [Related]
28. Inv(16) and eosinophilia in CMMoL.
Bennett JM
Cancer Genet Cytogenet; 1998 Feb; 101(1):81. PubMed ID: 9460508
[No Abstract] [Full Text] [Related]
29. Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group.
Nomdedeu M; Pereira A; Calvo X; Colomer J; Sole F; Arias A; Gomez C; Luño E; Cervera J; Arnan M; Pomares H; Ramos F; Oiartzabal I; Espinet B; Pedro C; Arrizabalaga B; Blanco ML; Tormo M; Hernandez-Rivas JM; Díez-Campelo M; Ortega M; Valcárcel D; Cedena MT; Collado R; Grau J; Granada I; Sanz G; Campo E; Esteve J; Costa D;
Leuk Res; 2017 Dec; 63():85-89. PubMed ID: 29121539
[TBL] [Abstract][Full Text] [Related]
30. Myelomonocytic leukemia with intracytoplasmic crystalline inclusions, double minute chromosomes and MYC amplification.
Geyer JT; Mathew S
Int J Hematol; 2017 Oct; 106(4):457-458. PubMed ID: 28755206
[No Abstract] [Full Text] [Related]
31. Isochromosome 14q in myeloid dysplastic disorder.
Solé F; Caballín MR; Coll MD; Woessner S; Besses C; Palou L; Egozcue J
Cancer Genet Cytogenet; 1991 Jul; 54(1):133-4. PubMed ID: 2065308
[TBL] [Abstract][Full Text] [Related]
32. [Acute transformation of chronic myelomonocytic leukemia with t(1;3) (p36;q21) abnormality].
Onishi Y; Nakamichi T; Maeda Y; Chinzei T; Nakagawa T; Saigo K
Rinsho Ketsueki; 1998 Jul; 39(7):519-25. PubMed ID: 9750460
[TBL] [Abstract][Full Text] [Related]
33. Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.
Hancock JC; Prchal JT; Bennett JM; Listinsky CM
Arch Pathol Lab Med; 1997 May; 121(5):520-3. PubMed ID: 9167610
[TBL] [Abstract][Full Text] [Related]
34. A myeloproliferative disorder associated with isochromosome 14q.
Saghir F; Abboud E; Veres C; Feldman L
Am J Med Sci; 2002 Sep; 324(3):166-9. PubMed ID: 12240716
[TBL] [Abstract][Full Text] [Related]
35. Absence of BCR-ABL rearrangement (with m-bcr breakpoint) in chronic myelomonocytic leukemia.
Henic N; Preudhomme C; Vanrumbeke M; Fenaux P
Leukemia; 1994 Oct; 8(10):1795-6. PubMed ID: 7934180
[No Abstract] [Full Text] [Related]
36. Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders.
Occhipinti E; Correa H; Yu L; Craver R
J Pediatr Hematol Oncol; 2006 Oct; 28(10):700-1. PubMed ID: 17023836
[No Abstract] [Full Text] [Related]
37. Partial deletion of 14q and partial duplication of 14q in sibs: testicular mosaicism for t(14q;14q) as a common mechanism.
Masada CT; Olney AH; Fordyce R; Sanger WG
Am J Med Genet; 1989 Dec; 34(4):528-34. PubMed ID: 2624263
[TBL] [Abstract][Full Text] [Related]
38. Translocation t(11;13) and deletion of chromosome 7 in a patient with acute myelomonocytic leukemia.
Pati A; Creasy M; Challinor PR; Ng JP; Harris RI
Cancer Genet Cytogenet; 1990 Apr; 45(2):261-3. PubMed ID: 2317774
[TBL] [Abstract][Full Text] [Related]
39. Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia.
Jeddi R; Gouider E; Benneji H; Mnif S; Ben Abid H; Belhadjali Z; Meddeb B
Pathol Biol (Paris); 2008 May; 56(3):162-3. PubMed ID: 18178033
[TBL] [Abstract][Full Text] [Related]
40. Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13).
Shin J; Kim M; Kim DB; Yeom JO; Lee HJ; Cho SG
Acta Haematol; 2008; 119(1):57-9. PubMed ID: 18268406
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
